Complete guides, comparisons and scientific analyses on peptides in skincare, health and biohacking.
An evidence-based look at the peptides athletes ask about most — what the science actually shows, where the WADA anti-doping rules draw the line, and the legal risks you need to understand before considering them.
How nootropic peptides like Semax, Selank, Dihexa, PE-22-28 and Epithalon influence BDNF, NGF and neuroplasticity — with mechanisms, dosing frameworks and the limits of current science.
How BPC-157, KPV, LL-37 and Larazotide are studied for leaky gut, IBS, SIBO and inflammatory bowel conditions, and what the research actually shows.
From anti-aging and hair to weight management, libido and recovery, here is what the evidence actually shows for women, plus dosing logic and hormonal safety considerations.
A head-to-head comparison of semaglutide and liraglutide — two generations of GLP-1 receptor agonists with very different dosing, efficacy and value.
A direct, evidence-based comparison of semaglutide 2.4 mg and tirzepatide — efficacy, safety, cost, and how to switch between them.
An evidence-based listicle covering the leading peptides studied for hypertrophy and tissue repair — with mechanisms, sample protocols, and realistic timelines.
A direct, evidence-based comparison of bioavailability, absorption kinetics, efficacy, protocols, and cost — so you can match the route to your goal.
A research-grounded look at copper peptides, thymosin beta-4 fragments and growth-hormone secretagogues — what the evidence supports, what remains speculative, and how protocols are structured.
A scientific comparison of two growth-hormone secretagogues — how they differ, why they are often combined, and what the research actually shows.
A practical, evidence-based protocol covering materials, the golden dilution formula, injection technique, storage, and the errors most beginners make.
From dosing math errors to contamination and storage failures — a practical, evidence-based guide to reconstituting research peptides correctly.